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A B S T R A C T
Oxide-polymer coatings were formed on the surface of the vanadium-free Ti–15Mo titanium alloy. The Ti alloy
surface was modified by the plasma electrolytic oxidation process, and then, the polymer layer of a poly (D, L-
lactide-co-glycolide) with doxycycline was formed. The polymer evenly covered the porous oxide layer and filled
some of the pores. However, the microstructure of the polymer surface was completely different from that of the
PEO layer. The surface morphology, roughness and microstructure of the polymer layer were examined by
scanning electron microscopy (SEM) and a confocal microscope. The results confirmed the effectiveness of
polymer and doxycycline deposition in their stable chemical forms. The drug analysis was performed by high-
performance liquid chromatography. The 1H NMR technique was used to monitor the course of hydrolytic de-
gradation of PLGA. It was shown that the PLGA layer is hydrolysed within a few weeks, and the polyglycolidyl
part of the copolymer is hydrolysed to glycolic acid as first and much faster than the polylactide one to lactic
acid. This paper presents influence of different microstructures on the biological properties of modified titanium
alloys. Cytocompatibility and bacterial adhesion tests were evaluated using osteoblast-like MG-63 cells and using
the reference S. aureus and S. epidermidis strains. The results showed that the optimum concentration of dox-
ycycline was found to inhibit the growth of the bacteria and that the layer is still cytocompatible.
1. Introduction
Implantology is a field of science that has a huge impact on the
quality of human life. It enables patients to recover efficiently and
supports the treatment of many serious diseases. Requirements for
materials from which implants are made include very good bioactivity,
lack of toxicity, excellent mechanical properties and resistance to fac-
tors in the surrounding implant environment. For the production of
implants dedicated to hard tissue, titanium and its alloys have been
widely used for many years. Currently, modern titanium alloys that do
not contain vanadium and aluminum, which are cytotoxic and ha-
zardous to human health, are desirable. In the passive layer, depending
on the elemental composition, there are nontoxic oxides, e.g., Nb2O5,
ZrO2, Ta2O5, and MoO3, that dissolve to a small extent in the en-
vironment of body fluids [1]. The very low solubility and diffusion of
elements in the form of ions or particles is due to the presence of a
passive layer on the surface of the material that delimits the tissue
environment from the substrate metal. For example, in a water en-
vironment where the pH value is close to that of human body fluids.
Additionally, the electric charge of particles dissolved in the tissue
environment has an effect on the biocompatibility of the substance, for
example, by affecting the properties of the proteins. Because the mo-
lecules of the abovementioned oxides are electrically neutral, they do
not cause undesirable reactions in contact with human tissues [1]. With
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regard to biomaterials, the properties of the surface layer are a sig-
nificant problem because this layer is in direct contact with the tissue
after implantation into the human body. Titanium has a high affinity for
oxygen; thus, a stable oxide layer is quickly formed on its surface.
However, the coating is not very biologically active, though it under-
goes various reactions, as a result of which its thickness, structure or
composition may change. Improvement in the bioactivity of the tita-
nium surface as well as modern titanium alloys can be achieved by
modifying the surface layer by various physical, chemical or electro-
chemical methods. Plasma electrolytic oxidation (PEO) is a well-known
method. It is used for the preparation of ceramic-oxide coatings on the
surfaces of light metals. The obtained layers are porous, are hard and
adhere well to the substrate. In addition, they are characterized by high
corrosion resistance, good biocompatibility and increased abrasion re-
sistance. The process runs under a high voltage. The thickness of the
barrier layer increases, but it is not uniform over the entire surface;
thus, the resistance and current vary. The gas evolves, the oxide layer
on the surface of the alloy is penetrated, and when the breakdown
voltage is reached, glow discharge appears. The porous structure of the
coatings can be intentionally enriched with chemical compounds or
solid particles from the solution. This is possible because glow dis-
charge causes a local increase in temperature and pressure. When
sparks disappear, places near discharges cool quickly, and the chemical
compounds including ceramic particles might be are built in. In this
way, the porous oxide layer may be enriched in substances (present in
the electrolyte solution) that stimulate the crystallization of hydro-
xyapatite, which supports the growth of cells on the surface of the
implant that can be introduced into the system [2,3].
Hybrid oxide-polymer layers can be a modern solution because they
combine the advantages of different surface modification techniques.
These coatings may be obtained using the dip-coating technique. It is an
easy and cheap method that involves immersing the object in a sol and
then pulling it out at a constant speed. It causes sol drainage and im-
mediate gelling. By changing the dipping speed, drying time and visc-
osity of the sol, the properties of the coating, such as its thickness and
morphology, can be changed. The dip-coating technique is useful for
materials with a complicated shape. One of the popular synthetic
polymers is poly (lactide-co-glycolide) (PLGA). Production of this co-
polymer has allowed overcoming the disadvantages of the pure starting
of the starting polymers and has facilitated the control of their prop-
erties, e.g., increasing the solubility [4–7]. These coatings may be en-
riched with biologically active substances, e.g., medicines, which can
effectively reduce the risk of bacterial infection after surgery. Research
into the controlled drug release system is underway. One of the worthy
antibiotics is doxycycline, which is the most stable substance in the
group of tetracyclines. It is a long-acting bacteriostatic antibiotic used
against gram-positive and gram-negative bacteria, such as Mycoplasma,
Brucella, Moraxella Catarrhalis, Streptococci, Staphylococci, Propioni-
bacterium anaerobes and Bacteroides fragilis. The drug is used in the
treatment of infections, e.g., in soft tissue, in the upper and lower re-
spiratory tract, in the gastrointestinal tract, in the genitourinary system,
for ophthalmic and other infections, and in the prevention of malaria.
However, the use of doxycycline over a long period of time results in
the resistance of certain strains to drug development, which is mani-
fested by the limitation of the degree of penetration of the antibiotic
inside the bacterial cells, as well as the action of “pushing” it back out
[8]. There are systems that, apart from using high-quality raw mate-
rials, facilitate therapeutic treatment through the use of a controlled
drug release system, which reduces the risk of rejection of the implant
by the human body [9].
Doxycycline is effectively absorbed from the gastrointestinal tract in
less than 2 h and is easily assimilated. The dosage depends on the pa-
tient's age, weight and grade of infection, where initially take a daily
dose of 100–200 mg. The drug is half-metabolized in the liver, and its
half-time is 18–22 h [10]. The stability of doxycycline depends on the
pH and temperature. There are different forms of the drug. The
proportion of these forms changes entirely depending on the pH of the
environment. Depending on the environment, the configuration
changes around the carbon atom as the stereogenic center. The lower
the pH value is, the better the stability of the drug. Studies have shown
that for a pH below 6, there is a slow process of transition to a less
active form, while an increase in pH increases the degree of deactiva-
tion of doxycycline [11].
The aim of this work was to study the formation of hybrid oxide-
polymer coatings containing a biologically active substance on the
surface of a titanium alloy: Ti–15Mo. The scope of this work includes
the modification of the Ti–15Mo titanium alloy surface by plasma
electrolytic oxidation, followed by the application of a degradable
polymer with doxycycline on the porous oxide layer. The morphology
of the modified surface and its qualitative composition were in-
vestigated in detail using scanning electron microscopy and confocal
microscopy. The process of hydrolytic degradation of the hybrid layer,
the release of the drug from the degrading surface and the biological
properties, such as the cytocompatibility and antibacterial activity,
were also examined using the most representative cells (osteoblast-like
cells MG-63) and the reference bacterial strains, such as Staphylococcus
aureus and Staphylococcus epidermidis.
2. Experimental
2.1. Surface pretreatment and coating formation
The titanium alloy Ti–15Mo (TM), with a composition of
14.73–14.98 wt% Mo, 0.15 wt% O, 0.06 wt% Fe, 0.08 wt% C, 0.016 wt
% N, 0.01% H, and Ti balance (BIMO Metals, Poland), was used for the
surface modifications. The samples were cylindrical in size: diameter of
10 mm and height of 5 mm. The surface was ground by using abrasive
papers with a gradation up to 1000 and then etched in a mixture of
4 M H2SO4 with 1 M HF. The sample was cleaned with distilled water in
an ultrasonic cleaner.
The Ti–15Mo alloy was anodized in a solution of 0.1 M Ca(H2PO2)2
(Alfa Aesar, Germany) with an initial current density of 100 mA/cm2
and a limited voltage of 300 V for 5 min (DC power supply (Kikusui,
Japan)) according to the procedure presented in Ref. [4].
The porous oxide layer was coated by a poly (D,L-lactide-co-glyco-
lide) (PLGA) (50/50), Mn = 19 000 (Sigma Aldrich, Poland), using a
dip-coating technique. The samples were placed in a chloroform solu-
tion (density of 1.48 g/cm3) with 5% PLGA (v/w). In the case of ap-
plying drug-containing layers, a solution consisting of PLGA and the
addition of 10 wt% doxycycline was used (Across, Poland). The dipping
speed of the samples was determined experimentally by measuring the
weight gain due to the application of the polymer layer and visual as-
sessment of the surface. The homogeneous coatings were obtained
when the parameters of the dip coatings were as follows: speed of im-
mersion and drawing of 1 cm/s, immersion time of 60 s and drying time
of 10 min.
2.2. Coating characterization
2.2.1. Surface morphology and roughness
The surface morphology of the modified titanium alloys was tested
using scanning electron microscopy (SEM) (Phenom Pro, backscattered
electron imaging, accelerating voltage of 15 keV). The hybrid oxide
layer with the drug was also analyzed using confocal microscopy to
determine the thickness of the oxide layer with doxycycline. Imaging
was performed using an Olympus FV 1000 confocal microscope with
40 × /NA 0.95 objectives. Z-stack images were generated using a
488 nm laser for the FITC dye. 3D data sets were analyzed as volume-
rendered data sets using Imaris (custom software developed by Bitplane
Scientific Software, Zurich, Switzerland). The surface roughness para-
meters for the investigated investigatedsamples were determined using
the 3D reconstruction software associated with the SEM. The arithmetic
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mean deviation of the roughness profile Ra and roughness height by 10
points in 5 selected places on the surface of the sample Rz were ob-
served.
2.2.2. Degradation of the hybrid oxide-polymer layer
Degradation of the polymer was examined by 1H NMR spectroscopy.
Polymer samples were placed in Falcon tubes and immersed in 5 ml of
artificial body fluid solution (0.7 g/dm3 NaCl, 0.5 g/dm3 KCl, 0.26 g/
dm3 Na2HPO4, 1.3 g/dm3 NaHCO3, 0.33 g/dm3 KSCN, and 0.13 g/dm3
urea – Across. Poland). Then, they were placed in an incubator at 37 °C
and shaken at 60 rpm. The samples were removed at weekly intervals
over a period of 28 days. The solution was lyophilized and analyzed by
1H NMR at 25 °C using a CDCl3 solvent. 1H NMR spectra were recorded
with a UNITY-INOVA spectrometer (Varian 300 MHz). The internal
standard used was tetramethylsilane (TMS).
2.2.2.1. Drug release. The stability of the doxycycline and drug release
from the coatings was analyzed by high-performance liquid
chromatography. The samples with coatings were immersed in 5 mL
of phosphate buffered saline (PBS w/o Ca, Mg, VWR) in Falcon tubes
and shaken at 60 rpm in an incubator at 37 °C. After 30 min, 100 μl
were collected from the 5 samples and filtered using a nylon filter of
0.2 μm. Then, to the Falcon tubes with the samples, 100 μl of fresh PBS
solution was added. The procedure was repeated for the three
independent series of samples.
2.2.2.2. High-performance liquid chromatography. HPLC analyses were
performed using a Merck-Hitachi chromatograph equipped with an L-
7100 pump and L-4500A diode array detector (DAD). Chromatographic
separations were carried out on a TSKgel ODS-100 V column,
150–4.6 mm, with a particle size of 5 (TOSOH BIOSCIENCE) at 22 °C.
Isocratic elution with 0.05% trifluoroacetic acid in water and
acetonitrile (70:30, v/v) was applied. The detection of doxycycline
was performed with the use of a DAD detector, where the wavelength
was set to λ = 270 nm. A calibration curve for the determined
doxycycline in an artificial saliva matrix was prepared. The
calibration curve was prepared for solutions in the range of
10–550 μg/mL. The calibration curve parameters were 13293 for the
slope (a) and 58491 for the intercept (b). The number of experimental
points taken for regression was n = 15. Every solution was injected
thrice. The volume of the solution was 20 μL for every single injection.
The limit of detection (LOD) and limit of quantification (LOQ) as a
signal-to-noise ratio was determined. The LOD for doxycycline was
3 ng/mL, while the LOQ was 10 ng/mL.
Studies on the doxycycline stability were conducted at four different
concentrations selected to represent the range of concentrations in real
samples. Doxycycline model solutions were prepared in PBS with con-
centrations of 10 μg/mL, 50 μg/mL, 100 μg/mL and 300 μg/mL. Three
parallel samples of a given concentration were prepared, and each
sample was injected twice. Analyses were performed immediately after
solution preparation (time zero) and then after 6.5 h, 13 h and 21 h of
storage at room temperature.
2.2.2.3. Cytocompatibility. Cell metabolic activity was evaluated using
the Alamar Blue reagent. The exact procedure was described in our
previous work [12]. Briefly, the samples were sterilized in ethanol and
then placed in 24-well plates. In each of them, 8000 osteoblast-like cells
were embedded in a 1 cm3 solution of the EMEM 66 medium. The
indicator was added to the cell culture, and the entire system was
maintained at 37 °C for 4 h in a humidified atmosphere containing CO2.
The number of active cells was determined from three samples. Tissue
culture polystyrene (TCPS) was used as a reference in cytocompatibility
test. A calibration curve and an average and a standard deviation were
used. Statistical analysis of the results obtained was also carried out
using Student's t-test. The viability, distribution and connection to the
ground of the deposited cells were analyzed using live/dead staining
and fluorescence microscopy.
2.2.2.4. Antibacterial properties. The antibacterial properties of the
material were evaluated using the solution with the doxycycline
released from the coatings after 1 h, 2 h, 4 h, 6 h, and 12 h of
immersion in artificial saliva at 37 °C, with shaking performed at
60 rpm. The bacterial strains used throughout this experiment were
Staphylococcus aureus (ATCC 25923) and Staphylococcus epidermidis
(ATCC 700296). The bacterial strains were precultured in the TSA
(Triptic Soy Broth) culture medium at 37 °C for 18 h (Incubator ES-20/
60, Biosan). Then, the bacteria were sent into the agar diffusion plate
(Diag-Med, Poland), and 100 μl of previously filtered solution with
doxycycline was added. The samples were cultured at 37 °C for 18 h
(Incubator ES-20/60, Biosan).
The solution collected after various times of doxycycline release was
also used to determine the minimal inhibitory concentration. Two
milliliters of the filtered solution with the drug was added to 2 mL of
the TSB with 106 CFU/mL of the bacteria (S. aureus (ATCC 25923) or S.
epidermidis (ATCC 700296)), and the optical density (OD) was mea-
sured using a densitometer (Densilameter, Erba Lachema). The samples
were cultured at 37 °C for 18 h, and the OD was again measured. The
results are presented as an average value obtained according to the
McFarland scale. The experiment was carried out for each bacterial
strain using 3 independent samples.
3. Results and discussion
The results of the test carried out for:
- the Ti–15Mo titanium alloy (TM sample),
- the titanium alloy after the plasma electrolytic oxidation process
(TM-PEO sample).
- the titanium alloy with the PLGA layer (TM-PEO-PLGA sample).
- the titanium alloy with the doxycycline-consisting polymer layer
(TM-PEO-PLGA-DOX) are presented below.
Surface morphology and roughness.
Fig. 1 shows the surface morphology of the Ti–15Mo alloy after the
plasma electrolytic oxidation process (Fig. 1a and b) and after coating
the anodized surface with a PLGA polymer layer (Fig. 1c and d).
Many pores were created under the anodization process as a result
of conditions prevailing during the anodizing process. When the oxide
barrier layer broke down, spark discharges caused the formation of
pores in the layers. The surface roughness for the TM-PEO sample was
as follows: Rz = 1.5 ± 0.3 μm and Ra = 0.5 ± 0.09 μm. In the case
of the TM-PEO-PLGA sample, the characteristic porous oxide layer was
still visible after the formation of an additional polymer layer. The
polymer layer reproduced the structure of the porous oxide layer, when
the layer was observed under SEM microscope. The microstructure of
the coatings was still porous after PLGA deposition. As a result of for-
mation of PLGA layer on previously anodized titanium alloy surface,
the value of the roughness parameters increased, and a greater differ-
ence was noted for Ra = 1.2 ± 0.2 μm than for Rz = 2.3 ± 0.5 μm.
Fig. 2 shows the 2D and 3D SEM images of the TM-PEO-PLGA-DOX
sample surface. The pores were still visible in the coatings, and the
particles of doxycycline were not detected by SEM. The modification of
the surface layer with the drug resulted in an increase in the mean value
of the Rz parameter and a decrease in the value of the Ra parameter in
relation to the layer containing only the polymer (Rz = 4.9 ± 0.9 μm,
Ra = 1.2 ± 0.1 μm). The coatings with the drug, which may find
application in medicine, were analyzed in detail using a confocal mi-
croscope. The coatings were immersed in a solution with SYTO9 and
then rinsed with water. Fig. 2c and d presents the microstructure of the
polymer layer with the drug deposited on the previously anodized Ti
alloy surfaces (TM-PEO-PLGA-DOX sample). It is clearly visible that the
microstructure of the polymer layer is completely different from those
A. Kazek-Kęsik, et al. Bioactive Materials 5 (2020) 553–563
555
obtained on the oxide layer. The polymer was irregular but formed a
coherent layer. The thickness of the polymer layer was measured at
representative locations in the optical image, and it is indicated that the
thickness of the polymer layer was between 22.1 and 39.1 μm.
The SEM images confirmed the formation of a porous oxide layer on
the surface of the titanium alloy as a result of plasma electrolytic oxi-
dation. The final results of the surface treatment strongly depends on
the electrochemical composition of the PEO process, and the bath
composition and substrate, as well [13,14]. The characteristic porous
structure of the coatings usually is composed of the chemical com-
pounds incorporated from the anodizing bath. In our case, the PEO
process was carried out in solution with calcium and phosphorus, and
these ions were built in the coatings. The chemical analysis of the PEO
coatings anodized in Ca(H2PO2)2 solutions were presented in our paper
[15]. If calcium or phosphate are built in, apatite may crystallize, which
is beneficial for bone tissue growth and the formation of a good con-
nection between the implant and a given bone. Formation of the apatite
on the polymer surface is favorable for osseointegration process [16].
3.1. Degradation of hybrid layers
The progress of hydrolytic degradation of the hybrid coatings con-
taining doxycycline was examined by the 1H NMR technique. Fig. 3
shows the spectra of the PLGA before degradation and of the PLGA
Fig. 1. SEM images of the anodized surface (A, B: TM-PEO sample) and the sample with the oxide and polymer layers (C, D: TM-PEO-PLGA).
Fig. 2. SEM images of the oxide-polymer layer with doxycycline (A, B: TM-PEO-PLGA-DOX sample), and images of the polymer layer loaded with doxycycline (C)
and the polymer layer thickness (D) determined by confocal microscopy.
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layer from TM-PEO-PLGA-DOX samples after 1–4 weeks period of de-
gradation carried out in the artificial body fluid solution at 37 °C.
The obtained spectra were compared with the spectrum of lactic
acid (LAc) solution in water (80%). The observed signals in spectra
were assigned to particular groups of protons: [A] (O)COCH–CH3 (m,
3H; 1.50–1.70 ppm), [B] CHOC(O) (m, 1H; at 5.10–5.35 ppm) and [C]
CH2OC(O) (m, 2H; 4.60–5.00 ppm). For each signal, the integral was
calculated, and the ratio of their values A:B:C was approximately 3:1:2,
which is consistent with the number of protons giving individual sig-
nals. When calculating the intensity ratio of signals A:C or B:C (after
dividing by the number of protons), the lactidyl (LA) to glycolidyl (GA)
units ratio was determined to be 1:1 in the initial polymer. During the
degradation process, the intensity of signals from the above groups
decreases, and after three weeks of samples immersion in the artificial
body fluid, the peak from methylene protons [C] practically disappears.
It means that polyglycolide part of copolymer is completely hydrolysed
after such period of time. The polylactidyl part undergoes hydrolysis
significantly slower. Basically, the products of PLGA degradation were
identified as a short-chain oligomers and low-molecular-weight hy-
droxyacids such as lactic (LAc) and glycolic acid. The chemical struc-
ture of polymer degradation products is presented in Fig. 3, with the
corresponding signals at 4.35–4.50 ppm (q, 1H, CH3(OH)CHC(O)OH)
[B′], 4.25–4.35 ppm (s, 2H, HO(O)CCH2OH) [C′], and 1.45–1.55 ppm
(d, CH3(OH)CHC(O)OH) [A′]. Table 1 presents changes in the ratio of
the number of lactidyl to glycolidyl units and the percent amount of LAc
Fig. 3. 1H NMR spectra of PLGA before degradation and of PLGA layer of the TM-PEO-PLGA-DOX samples obtained during the 4-week degradation process in the
artificial body fluid solution.
Table 1
Ratio of the amount of lactide to glycolide units during 5 weeks of the TM-PEO-
PLGA-DOX layer degradation.
Degradation time
[weeks]
Ratio of LA: GA
units in the
polymera [mol/mol]
Ratio of LA units in
the polymer to LAcb
[mol/mol]
Content of the
LAc [%]
0 1 : 1 1 : 0 0
1 1 : 0.38 (2.6 : 1) 1 : 0.28 (3.5 : 1) 22.0
2 1 : 0.2 (4.8 : 1) 1 : 0.38 (2.6 : 1) 27.6
3 1 : 0 1 : 0.77 (1.3 : 1) 43.5
4 1 : 0 0.52 : 1 (1 : 1.9) 65.8
5 1 : 0 0.46 : 1 (1 : 2.2) 68.5
a Calculated on the basis of the intensity ratio of signals A and B.
b Calculated on the basis of the intensity ratio of signals C and C′.
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formed during 5 weeks of degradation. At the beginning of the ex-
periment, the ratio of LA:GA units is 1:1. It changes in a relatively short
time, and after the first week of being in the artificial body solution, it is
1:0.38, while after two weeks, it drops to 1:0.20. At the same time, the
lactic acid content increases. After 7 days of immersion, it is 22%, and
after 14 days, it is slightly higher – 26%. After 3, 4, and 5 weeks of
conducting the experiment, signals indicating the presence of glycolide
units in the polymer structure are undetectable; thus, the ratio of LA:GA
units is 1:0. The largest increase in LAc content is observed between the
second and fourth weeks. Finally, after 5 weeks in the artificial body
solution, its content is 68.5%.
It can be concluded that as the degradation process progresses, the
percentage of lactic acid increases slowly because hydrolysis of PLGA
chains proceeds slower in polylactidyl part than that of polyglycolidyl
one. These changes indicate the PLGA degradation process in the body
fluid environment, which is in line with expectations and confirms the
possibility of using the tested polymer as a matrix for the controlled
drug release systems.
The hydrolytic degradation of PLGA occurs in a short time with the
increase in lactic content. E. Vey et al. reported that the degradation
rate constant for polylactide is smaller than for polyglycolide and may
differ depending on the lactic unit content [17]. Poly (lactide-co-gly-
colide) is used in many drug delivery systems, combined with various
drugs and in various carriers [18]. The PLGA is widely used for nano-
particles formation and loaded by various drugs [19]. Drug release play
a key role in the biomaterial characterization, however the stability of
the drugs plays a key role in the beginning of the drug release de-
termination.
3.1.1. Drug release and its stability
The concentration of doxycycline in artificial body fluid was de-
termined by high-performance liquid chromatography. This technique
allows confirming that the drug was not degraded during the elution
process from the modified surface. However, doxycycline is unstable in
artificial saliva, and the time of its stability depends significantly on its
concentration in solution. Fig. 4A presents the results of the drug con-
centrations in the artificial saliva after the various times of exposure in
the vials.
It was determined that the concentration of doxycycline sig-
nificantly influenced its stability in the artificial saliva solution. When
the concentration of doxycycline was higher than 75 μg/mL, more than
90% of the doxycycline was stable up to 21 h. The stability of dox-
ycycline drastically decreased when its concentration in the solution
was 10 μl. The primary content of doxycycline was below 90% after
6.5 h, then decreased below 80% after 13 h and then significantly de-
creased below 70% after 21 h. The marked bars in each column re-
present the coefficient of variation value. Concentration of doxycycline
in the matrix determined after 21 h differs statistically from previous
concentration values. The results indicate that the determined amount
of doxycycline in the solution will be lower than the initial con-
centration due to its low stability in the solution. Thus, the doxycycline
released from the polymer coatings was determined up to 10 h to obtain
reliable results. This time is also the most important to prevent bacterial
adhesion and biofilm formation.
Fig. 4B presents the concentration of the doxycycline released into
the artificial saliva after up to 10 h of incubation at 37 °C. The first
hours of drug release are the most important in bacterial adhesion and
biofilm formation. The total concentration of doxycycline loaded into
the polymer layer was 385.35 μg/cm2. After 30 min of material im-
mersion, more than 23% of the loaded drugs were released from the
coating (91.67 μg/mL). Then, the concentration of doxycycline released
into the artificial saliva slightly increased. The difference between the
30 min and 10 h concentrations of drug released from the material was
32.84 μg/mL. After 10 h of coating immersion, 32.3% of doxycycline
was released.
Doxycycline presents 18 different forms depending on the pH of the
solution. Due to the similarity of the physicochemical properties of the
compounds, it is not always possible to determine each individual form.
In this study, we used HPLC-DAD system with C18 stationary phase, the
pH of the mobile phase was 2. The pH of the matrix solution to which
the drug was released from the surface was also important. The applied
measurement conditions allowed to observe three signals coming from
doxycycline. The chromatographic system used in the study made it
possible to separate the three of compound form and to validate the
chromatographic procedure. Hence, the reported changes in drug
concentration during release from the hybrid layer to the artificial
saliva solution are the sum amounts for the forms present at the given
pH values. Even if the percentage of individual antibiotic varieties is
known in a given pH environment, the concentration of each of these
forms in the artificial saliva solution cannot be unequivocally de-
termined based on the absorbance value. The largest variety of forms
occurs in the pH range from 6 to 8, and their content is often very
similar. The accurate determination of the concentration of a particular
substance would be inexact; thus, we presented forms, the occurrence
of which at a given pH is most likely [11,20].
Fig. 4. Concentration of doxycycline after various exposure times in artificial
saliva (A) and concentration of the doxycycline released from the oxide-
polymer layer into artificial saliva, and the total drug concentration loaded into
the coating (B). The changes are correlated with the concentration of doxycy-
cline and strongly influence the determination of the amount of doxycycline
released from the coating.
A. Kazek-Kęsik, et al. Bioactive Materials 5 (2020) 553–563
558
During the experiment, the pH value of the taken solutions was also
measured. The results are presented in Fig. 5.
The form in which doxycycline occurs depends on the pH of the
environment. Hence, knowing the pH of the solution into which the
drug is released, we can estimate the percentage of each variety of the
antibiotic in the sample. The differences in the pH were clearly ob-
served. The initial pH of the coated Ti alloy with doxycycline in arti-
ficial saliva was 7.4. After 30 min, the pH decreased to 7.16. Then, the
pH slightly increased, and after 10 h, it was 7.65. The pH significantly
changed 24 h after the materials were coated (up to 7.88) and after 5
days (8.36), 21 days (8.75) and 28 days (8.68).
3.1.2. MG-63 osteoblast-like cell cytocompatibility
Fig. 6 shows the results of MG-63 osteoblast-like cell viability stu-
dies after 1, 3 and 7 days.
The number of viable cells was determined using the Alamar Blue
dye, and the results are expressed as a reduction rate. The higher the
degree of Alamar Blue reduction, the greater the number of live cells
marked on the surface of a given titanium alloy sample. After 24 h of
the experiment, the majority of viable cells were determined on the
surface of the TM-PEO-PLGA-DOX sample (percent of Alamar Blue re-
duction was 2.85%), slightly less in the case of TM-PEO-PLGA (2.28%)
and the least on the unmodified alloy Ti–15Mo (0.41%).
After 3 days of incubation, the reduction rate was the highest for the
TM-PEO-PLGA sample – 6.75%. This is a significant increase compared
to the first day (2.28%). In the case of drug-containing layers, the
number of live cells decreased: for the sample with 5% by weight of
doxycycline, it was only slightly lower – 1.89%; for the sample with a
higher antibiotic content, the difference was greater – 1.72%. Thus, the
degree of Alamar Blue reduction on modified surfaces differing in drug
content became similar; the cell culture was influenced in a similar
manner. After 7 days, the percent of reduction increased for all of the
samples, but the highest increase was again noted for the TM-PEO-
PLGA – 21.17%. In the case of samples containing doxycycline (TM-
PEO-PLGA-DOX) the proliferation was 10.30%. The tendency of a
slightly worst cell proliferation on the surface of the layer containing
the smaller amount of drug was observed. After 3 and 7 days of culture,
the lowest Alamar Blue reduction rate was observed for the sample after
only the PEO process – 0.47% and 2.66%, respectively. The results
indicate that the post-treatment technique increase the cytocompat-
ibility of the investigated Ti alloy.
Fig. 7 shows the morphology of osteoblast-like cells after 1, 3 and 7
days of incubation.
To characterize the morphology of the surface of living cells and the
number of dead cells, live/dead staining was used. Optical microscopy
with a fluorescent attachment allows the observation of living cells,
which, under these conditions, are green, while dead cells are red. After
24 h of incubation, most cells were adhered to the surface of the TM-
PEO-PLGA sample, while the least number of were adhered to the
surface of the pure Ti–15Mo alloy. For each sample, the cells were
flattened, which indicates their good adhesion to the substrate. Their
shape was also extended; only for the TM-PEO-PLGA-DOX surfaces
were they more spherical. The arrangement on the surface of the TM
was homogenous, whereas on the TM-PEO-PLGA and TM-PEO-PLGA-
DOX samples, agglomerates of living cells were visible. After 24 h, only
single dead cells were observed on the examined surfaces. After 3 days
of the experiment, the number of living cells increased for each of the
samples, with the highest dye reduction rate recorded for the TM-PEO-
PLGA sample (6.75%), which confirms the largest number of preloaded
cells visible in the picture (Fig. 7). The smallest coverage level was
observed for the TM-PEO surface, which, in relation to the state after
24 h, increased by only 0.06% points. Based on the images (Fig. 7), the
cells were found to be well flattened, to be regularly spaced and to not
form agglomerates, especially in the TM-PEO-PLGA and TM-PEO-PLGA-
DOX layers. After 7 days, the Alamar Blue reduction rate increased for
each of the samples tested; thus, the number of osteoblast-like adhered
cells again increased. After 3 days of incubation, the largest amount was
on the surface of TM-PEO-PLGA and subsequently on TM-PEO-PLGA-
DOX. They were well flattened and arranged in a homogenous manner.
A significantly smaller number of cells were adhered to the TM-PEO
layer. After both 3 days and 7 days of the experiment, dead cells were
very rarely observed, being visible as red cells.
T. Wang et al. investigated the biological properties of PLGA. The
polymer positively influences the growth of bone cells and forms a
permanent connection between tissue and titanium implants.
Investigations with the use of mouse MC3T3-E1 cells proved no toxic
effects of PLGA and its biodegradation products and hence good
Fig. 5. Changes in the pH of artificial saliva during immersion of the oxide-
polymer layer with doxycycline (TM-PLGA-PEO-DOX).
Fig. 6. The number of viable MG-63 cells on the modified Ti–15Mo titanium
alloy surfaces, expressed as the Alamar Blue reduction rate. Statistical sig-
nificance from the TCPS (*) and unmodified Ti–15Mo (#) are is marked; *,
#p < 0.05, **, ##p < 0.01 and ***, ###p < 0.001. (For interpretation of
the references to colour in this figure legend, the reader is referred to the Web
version of this article.)
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biocompatibility of the polymer [21]. L. J. Smith et al. also agreed that
coating the anodized titanium surface with PLGA enhances the pro-
liferation and adhesion of osteoblast cells to the substrate [22]. The
same effect was also obtained in the case of titanium grade 4 coated
with zirconium oxide/polyethylene glycol with various percentages of
PEG content [23].
The utility of PLGA in implantology was also analyzed by L. Zhao
et al. The polymer was applied to bioceramics composed of calcium
silicate. The bioactivity of the obtained materials was evaluated by
immersion in simulated body fluid and assessment of the amount of
crystallized apatite on the modified surface. Applying PLGA does not
impair the ability to deposit apatite molecules. The thinner the polymer
layer is, the higher the concentration of apatite. In addition, PLGA
coatings have a good impact on the pH value of the environment sur-
rounding the implant by binding the alkaline ions derived from the
decomposition of calcium silicate by acidic products of polymer de-
gradation. Reducing the pH value is also beneficial for cell growth,
proliferation, spreading and morphology on the modified surface [24].
Wei Ji et al. proposed another solution: modification of the PLGA-based
nanofibrous scaffolds with nanoapatite particles [25]. The addition of
nanoparticles results in slowing down the degradation process. This is
marked by the higher molecular weight and depends on the number of
nanoapatite particles acting as a weak alkaline salt, giving the buffering
effect. Investigations showed fewer inflammatory cells and foreign
body giant cells in the case of samples with nanoapatitic particles. The
authors claim that this is due to a lower degree of polymer biode-
gradation. In addition, acidic degradation products are homogenously
distributed on the implant surface. As in our case, the polymer products
are acidic. However, the pH measurements near the coatings indicate
alkalization. Probably, it is an effect of changing in the doxycycline, and
possibility of phosphates-based compounds formation on the surface of
the sample. Especially, that the Ti–15Mo surface was anodized in cal-
cium hypophosphate solution and calcium and phosphorous
compounds exist in the coating [15]. It is possible that the small cal-
cium-phosphate nanoparticles were formed on the surface, or the
changes occurred in the solution, thus the pH was changed. The ex-
planation of the changing the doxycycline is also connected with the
results of the microbiology test. Where, the doxycycline released after
4 h was less active against bacteria, than the solution with doxycycline
released up to 4 h.
3.1.3. Bacteria
To evaluate the effectiveness of surface modification of the Ti–15Mo
titanium alloy, the antibacterial activity of hybrid coatings against the
Staphylococcus aureus (ATCC 25923) and Staphylococcus epidermidis
(ATCC 700296) bacteria was examined. Initially, the antibacterial
properties of the modified surfaces containing 5% (by weight of the
polymer) doxycycline were tested. However, this concentration was not
enough to significantly inhibit bacterial growth. Therefore, studies with
more antibiotics (10% vs. PLGA weight) were performed. This amount
was sufficient to inhibit the growth of both bacteria (S. aureus and S.
epidermidis). Fig. 8 presents the inhibition zones of bacterial strains after
culture with artificial saliva, with drug released from the coatings after
1, 2, 4, 6, and 12 h of sample immersion, and the control (artificial body
fluid).
In the case of S. epidermidis, the lowest inhibition of bacterial growth
was observed after 2 h (21 mm), and the greatest inhibition was ob-
served after 4 h (32 mm). The effect of the drug clearly increased be-
tween these measurement points. Then, the drug weakened again, and
the inhibition zone decreased. Significantly greater sensitivity to dox-
ycycline was shown by S. aureus. The diameter of the growth inhibition
zone exceeded 30 mm even for the solution obtained after 1 h of sample
immersion – 36 mm, which was the best result. The same effect was
noted for the sample after 12 h of incubation. Inhibition zone sizes
remained at a similar level throughout the experiment, which suggests
better stability of the drug on S. epidermidis than that on S. aureus.
Fig. 7. Fluorescence microscopy images of the tita-
nium alloy surfaces and reference samples after 1, 3
and 7 days of culture. Live/dead staining, where
green indicates the live cells and red indicates the
dead cells. (For interpretation of the references to
colour in this figure legend, the reader is referred to
the Web version of this article.)
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Despite slight differences, the smallest size was obtained for the solu-
tion after 4 h of incubation (34 mm).
The antibacterial activity was also characterized by the number of
bacteria colonies expressed using the McFarland scale. Their amount
was determined after 18 h of incubation and then compared with the
initial quantity, thus assessing the multiplication of bacteria. As shown
in Fig. 9, a significantly larger increase in the number of colonies was
observed in the case of Staphylococcus aureus than for the Staphylococcus
epidermidis strain.
The number of colonies varied depending on the time of sample
immersion, showing a tendency to decrease in the range of up to 6 h of
immersion. In the case of samples that were immersed for more than
6 h, the number of bacteria again increased. However, the number of
bacterial colonies ranged from 117 CFU/mL to 540 CFU/mL. In the case
of Staphylococcus epidermidis, the inhibition of bacterial growth was
already observed for samples obtained after 1 h of immersion. The
number of bacteria that occurred during the 24 h of the experiment was
below the limit of quantification. Doxycycline released from hybrid
layers showed greater efficacy in inhibiting the growth of new bacterial
colonies in the case of Staphylococcus epidermidis than in the case of
Staphylococcus aureus.
R. Misra et al. reported that entrapment doxycycline in polymeric
PLGA-PCL nanoparticles improves the antibacterial properties of the
drug against E. coli and that increasing the PLGA content has a
beneficial effect on the efficiency of encapsulation. Although the drug
has high antibacterial activity, the use of a polymeric system results in a
decrease in minimum inhibitory concentration and minimum bacter-
icidal concentration. The authors claim that this outcome may be
caused by the easier penetration of small molecules of the drug into the
interior of the bacteria cells [26]. The antibacterial properties of dox-
ycycline against Staphylococcus epidermidis were also confirmed by R.
Xing et al. The bacterial growth was stopped, and the inhibition zones
on agar plates were observed. The higher the drug concentration is, the
greater the degree of inhibition of biofilm formation at the titanium
alloy surface [27]. Doxycycline is a broad-spectrum antibiotic and may
also be used for other bacterial strains. F. Tamimi et al. tested the an-
tibacterial activity against gram-negative Actinobacillus actinomyce-
temcomitans and Bacteroides frosthytus, which are periodontal pathogens
responsible for many periodontal diseases. A wide inhibition zone was
observed for Actinobacillus actinomycetemcomitans, but the strongest
effect of the antibiotic was demonstrated in the case of Bacteroides
frosthytus, where practically 100% of the bacteria were killed [28]. The
antibacterial activity of doxycycline differs depending on the bacteria
type and becomes higher as the drug concentration in the system in-
creases [29]. The minimum inhibitory concentration (MIC) was eval-
uated using four strains: K. pneumonia, P. aeruginosa, S. aureus, and E.
coli. The highest value was measured for P. aeruginosa (25 μg/mL), and
the lowest, for S. aureus (1 μg/mL). Doxycycline shows the ability to
Fig. 8. Inhibition zones of reference (A) Staphylococcus aureus (DSM 24167) and (B) Staphylococcus epidermidis (ATCC 700296) after culture with artificial saliva (1)
and with the doxycycline released from the coating after 1 h (2), 2 h (3), 4 h (4), 6 h (5), and 12 h (6) into the artificial body fluid.
A. Kazek-Kęsik, et al. Bioactive Materials 5 (2020) 553–563
561
inhibit bacteria growth for all of the tested strains [30]. In our case, the
concentration of the drug released after 30 min of coatings immersion
in artificial body fluid was higher, equal 91.67 μg/mL. This con-
centration was enough to inhibit bacteria (S. aureus and S. epidermidis)
and large inhibition zones were obtained (36 mm and 25 mm, respec-
tively). When concentration of drug increased up to 110.63 μg/mL no
significant difference was observed in the inhibition of S. aureus, where
the S. epidermidis was more sensitive and the inhibition zone of bac-
teria increased. After 4 h of bacteria culture, the activity of the drug
slightly decreased. After 4 h the pH of the solution where the drug
released also was changed, and it might influence on the doxycycline
activity. When the concentration of the drug increased due to longer
time of the coating immersion, the activity of the drug againt bacteria
increased, as well. It was reported, that bacteriostaticity is achieved by
stopping protein biosynthesis. Furthermore, the drug has the ability to
reduce collagenase activity. These phenomena are caused by the for-
mation of a permanent connection between the antibiotic and the 30S
ribosomal subunit and, rarely, 50S. This results in the properties of the
aminoacyl-tRNA –mRNA – ribosome complex changing by blocking the
connection [8].
4. Conclusions
This research confirmed the effectiveness of using plasma electro-
lytic oxidation and the dip-coating technique for the formation of a
hybrid oxide – poly (lactide-co-glycolide) layer, which may additionally
contain a biologically active substance. The differences in the pH of the
solution strongly affect the stability of the doxycycline and the con-
centration of the doxycycline released from the coating. The polymer
layer will degrade in more than 4 weeks, however, the doxycycline
released from the coatings after 1 h inhibits the growth of bacteria. For
medical applications, this result indicates that the potentially implanted
surface might be protected and that the risk of septic inflammation
decreases. On the modified surfaces of the Ti–15Mo alloy, the adhesion
and proliferation of osteoblast-like cells occurred, which indicated that
the surfaces were cytocompatible. Investigations carried out using
Staphylococcus aureus (ATCC 25923) and Staphylococcus epidermidis
(ATCC 700256) strains confirmed that the amount of loaded doxycy-
cline was sufficient to inhibit bacterial growth. These results confirmed
the utility and efficiency of using hybrid oxide-polymer layers as po-
tential biomaterials for implantology, especially for dental implants.
This kind of coating may reduce the risk of postoperative infections and
complications.
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